We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+29.97%
1 Year Est. Return
+57.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.46B
AUM Growth
+$496M
Cap. Flow
+$126M
Cap. Flow %
5.12%
Top 10 Hldgs %
38.02%
Holding
188
New
26
Increased
91
Reduced
27
Closed
22

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$52.1M
2
DXCM icon
DexCom
DXCM
+$46.7M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.53M
4
PH icon
Parker-Hannifin
PH
+$5.29M
5
AVGO icon
Broadcom
AVGO
+$5.08M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$24.9M
2
KLAC icon
KLA
KLAC
+$21.4M
3
WDAY icon
Workday
WDAY
+$21M
4
FIX icon
Comfort Systems
FIX
+$14.1M
5
TSM icon
TSMC
TSM
+$8.27M

Sector Composition

Rank Sector Weight
1 Technology 39.09%
2 Financials 11.79%
3 Communication Services 11.56%
4 Industrials 11.01%
5 Healthcare 10.91%

No holdings matched the selected filter criteria.

Similar funds

Smith Group Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Smith Group Asset Management held 188 positions worth $2.46B, up 25% from $1.96B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Smith Group Asset Management deployed $126M of net new capital in Q2 2026, opening 26 new positions and adding to 91 existing holdings. Its largest new stake was DexCom: 701,347 shares worth $47.2M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 32% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was KLA, an estimated $21.4M trimmed.

  • Smith Group Asset Management's largest Q2 2026 buy was DexCom: 701,347 shares worth $47.2M.
  • Smith Group Asset Management added most to Lam Research in Q2 2026, an estimated $52.1M increase.
  • Smith Group Asset Management's biggest Q2 2026 reduction was KLA, cutting an estimated $21.4M.
  • Smith Group Asset Management fully exited Vertex Pharmaceuticals in Q2 2026, selling an estimated $24.9M.
  • Smith Group Asset Management's ten largest holdings make up 38% of its $2.46B portfolio in Q2 2026.
  • Smith Group Asset Management opened 26 new positions and closed 22 in Q2 2026.
  • Smith Group Asset Management's portfolio value rose 25% quarter-over-quarter to $2.46B.

Based on Smith Group Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.